Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
How Efficiency Checklists Help Hospitals Save Energy, Water and Money
Intermountain Healthcare Receives $50M Gift for Standalone Children's Hospital
Arrowhead Regional Medical Center Reports Data Breach via Third Party
Safety Synergy: Infection Prevention That Protects Patients and Workers
Prefabricated Wall Panels Speed UCF Lake Nona Medical Center Construction